Home/Filings/4/0001213900-25-083535

4//SEC Filing

Gracias Antonio J. 4

Accession 0001213900-25-083535

CIK 0001802665other

View on SEC.gov Company Profile

Filed

Sep 1, 8:00 PM ET

Accepted

Sep 2, 5:45 PM ET

Size

24.2 KB

Accession

0001213900-25-083535

Insider Transaction Report

Form 4

Period: 2025-08-28

Harmony Biosciences Holdings, Inc.HRMY

Gracias Antonio J.

Director

Transactions

Other
Common Stock
2025-08-28−6,618,033→ 0 total

Holdings

Common Stock
(indirect: See Footnote)
23,714
Common Stock
(indirect: See Footnote)
29,497
Common Stock
(indirect: See Footnote)
437,619
Common Stock
(indirect: See Footnote)
50,423
Common Stock
(indirect: See Footnote)
38,275

Valor Equity Capital IV LLC

10% Owner

Transactions

Other
Common Stock
2025-08-28−6,618,033→ 0 total

Holdings

Common Stock
(indirect: See Footnote)
38,275
Common Stock
(indirect: See Footnote)
29,497
Common Stock
(indirect: See Footnote)
50,423
Common Stock
(indirect: See Footnote)
437,619
Common Stock
(indirect: See Footnote)
23,714

VALOR EQUITY PARTNERS IV L.P.

10% Owner

Transactions

Other
Common Stock
2025-08-28−6,618,033→ 0 total

Holdings

Common Stock
(indirect: See Footnote)
29,497
Common Stock
(indirect: See Footnote)
38,275
Common Stock
(indirect: See Footnote)
437,619
Common Stock
(indirect: See Footnote)
23,714
Common Stock
(indirect: See Footnote)
50,423

Valor IV Pharma Holdings, LLC

10% Owner

Transactions

Other
Common Stock
2025-08-28−6,618,033→ 0 total

Holdings

Common Stock
(indirect: See Footnote)
50,423
Common Stock
(indirect: See Footnote)
437,619
Common Stock
(indirect: See Footnote)
38,275
Common Stock
(indirect: See Footnote)
23,714
Common Stock
(indirect: See Footnote)
29,497

Valor Management L.P.

10% Owner

Transactions

Other
Common Stock
2025-08-28−6,618,033→ 0 total

Holdings

Common Stock
(indirect: See Footnote)
38,275
Common Stock
(indirect: See Footnote)
29,497
Common Stock
(indirect: See Footnote)
437,619
Common Stock
(indirect: See Footnote)
50,423
Common Stock
(indirect: See Footnote)
23,714

Valor Equity Associates IV L.P.

10% Owner

Transactions

Other
Common Stock
2025-08-28−6,618,033→ 0 total

Holdings

Common Stock
(indirect: See Footnote)
50,423
Common Stock
(indirect: See Footnote)
38,275
Common Stock
(indirect: See Footnote)
23,714
Common Stock
(indirect: See Footnote)
29,497
Common Stock
(indirect: See Footnote)
437,619

Sabater Juan A.

Director

Transactions

Other
Common Stock
2025-08-28−6,618,033→ 0 total

Holdings

Common Stock
(indirect: See Footnote)
437,619
Common Stock
(indirect: See Footnote)
50,423
Common Stock
(indirect: See Footnote)
38,275
Common Stock
(indirect: See Footnote)
29,497
Common Stock
(indirect: See Footnote)
23,714

VALOR EQUITY PARTNERS IV-A L.P.

10% Owner

Transactions

Other
Common Stock
2025-08-28−6,618,033→ 0 total

Holdings

Common Stock
(indirect: See Footnote)
29,497
Common Stock
(indirect: See Footnote)
50,423
Common Stock
(indirect: See Footnote)
23,714
Common Stock
(indirect: See Footnote)
437,619
Common Stock
(indirect: See Footnote)
38,275

VALOR EQUITY PARTNERS IV-B L.P.

10% Owner

Transactions

Other
Common Stock
2025-08-28−6,618,033→ 0 total

Holdings

Common Stock
(indirect: See Footnote)
50,423
Common Stock
(indirect: See Footnote)
23,714
Common Stock
(indirect: See Footnote)
38,275
Common Stock
(indirect: See Footnote)
29,497
Common Stock
(indirect: See Footnote)
437,619

Footnotes (7)

[F1]In-kind pro rata distribution by Valor IV Pharma Holdings, LLC, without consideration.
[F2]Shares received in distribution described in footnote 1.
[F3]Held by Valor Management L.P.
[F4]Held by Antonio Gracias.
[F5]Held by AJG Growth Fund LLC, an entity controlled by Mr. Gracias.
[F6]Held by Juan Sabater.
[F7]Held by Tamal, LLC, an entity controlled by Mr. Sabater.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Harmony Biosciences Holdings, Inc.

CIK 0001802665

→

Entity typeother

Related Parties

filerCIK 0001495158

Filing Metadata

Form type: 4
Filed: Sep 1, 8:00 PM ET
Accepted: Sep 2, 5:45 PM ET
Size: 24.2 KB

View on SEC.gov